HonorStocks Biotech Gold Oil Mining China Asian MENU
Biotech Gold Oil Mining China Asian
Find Tomorrow's Winners Today

Stock technical analysis
Rating Flag Rating Flag Rating Flag Rating Flag Rating Flag
sell neutral buy
Bionano Genomics, Inc. (BNGO)
7.62  -0.24  (-3.05%) 06-21 02:12
Open: 7.8 High: 7.93
Pre.close: 7.86 Low: 7.44
Volume: 18,474,941 Ave vol: 23,875,593
52w High: 15.69 52w Low: 0.43
MA(50): 6.308 MA(200): 6.949
EPS: -0.251 P/E Ratio: 0
Company profile
Exchange: NASDAQ
Sector: Healthcare
Industry: Diagnostics & Research
Website: http://bionanogenomics.com
Market Cap (M): 2,125
Shares Out (M): 279
BioNano Genomics, Inc. is a life sciences instrumentation company, which focuses on genome analysis space. The company is headquartered in San Diego, California and currently employs 77 full-time employees. The firm develops and markets the Saphyr system. The Company’s products include Sequencing for Discovery Research and Cytogenetics. Sequencing alone, however, is significantly limited due to its inability to reveal structural variations. Cytogenetics provide a clinical diagnosis, cytogenetic tests detect known variations that are linked to specific diseases or therapeutic responses. Saphyr system is platform for ultra-sensitive and ultra-specific structural variation detection that enables researchers and clinicians to accelerate the search for new diagnostics and therapeutic targets and to streamline the study of changes in chromosomes, which is known as cytogenetics. Sequencing for Discovery Research is primarily used to find single nucleotide variations responsible for disease or therapeutic response.
Technical analysis
Overall: Neutral
MA: Bullish MACD: Bullish
KDJ: Bullish RSI: Bearish
Target 1: 10.65 Target 2: 12.44
Resist 1: 9.12 Resist 2: 10.65
Support 1: 6.57 Support 2: 4.99
Company key metrics
Revenue per Share: 0.064
Net Income per Share: -0.3092
Cash per Share: 0.2892
Book Value per Share: 0.2639
Price to Sales: 172.7639
Price to Book Value: 41.8734
Earnings Yield: -0.028
Dividend Yield: 0
Debt to Equity: 0.4654
Debt to Assets: 0.4196
Financial analysis
Price to Book Value: Outperform
Return on Assets: Neutral
Return on Equity: Neutral
Discounted cash flow: Outperform
Price to Earnings: Underperform
Debt to Equity: Neutral
Stock Charts

HonorStocks, Find Tomorrow's Winners Today

©HonorStocks.com | U.S. stock markets, stock quotes and stock analysis. Data and information is provided for informational purposes only, is not intended for trading purposes and is not investment advice. Neither HonorStocks.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. Market data provided by: IEX and Financial Modeling Prep

Privacy Policy: Third parties, including Google, may be placing and reading cookies on your browsers, or other methods to collect information as a result of ad serving on this website. Google's use of advertising cookies enables it and its partners to serve ads to you based on your visit to this site and/or other sites on the Internet. You may opt out of personalized advertising by visiting Ads Settings. If you choose to use this website, you agree to the collection and use of information in relation to this policy. The information collected is used for providing and improving the ads Service. We will not use or share information with anyone, and we do not store any data from users.